Dr Annalisa Morgan reflects on incorporating new treatments discussed at the 2025 ACTRIMS Forum into clinical practice.

A simple treatment algorithm to aid in the selection of appropriate DMTs reduces racial disparities in patients with ...

Studies have shown that starting a high-efficacy DMT like Tysabri earlier in the disease course can also lead to less ...

He cited data that show about 40% of patients with MS aged older than 60 years in the United States still use DMT. Peak use occurs between age 41 to 50 years. Corboy reviewed data from the DISCOMS ...

Thousands of NHS patients in England with multiple sclerosis (MS) are set to benefit from a life-changing ‘take at home’ tablet, as the NHS becomes the first healthcare system in Europe to roll it out ...

“It will also benefit patients considering starting a family, as it’s safe to get pregnant six months after the final course ...

as it’s safe to get pregnant six months after the final course of treatment – which is less restrictive than many other DMT options. “We’re so glad that more people with MS will now be ...

This includes those who experience highly active relapsing MS despite having undergone a full and adequate course of treatment with at least one disease-modifying therapy (DMT) or patients with ...

the identification of markers associated with a prolonged non-disabling course of MS would be very useful in counseling patients, particularly when advising on the initiation of a DMT. Doggrell ...

Ms Davy told the committee that the company has changed how it checks for water contamination since the crisis in Brixham, Devon, last year. The outbreak last May left some people in hospital and ...